-
1
-
-
0035200432
-
Neuronal instability: implications for Rett's syndrome
-
Azmitia E.C. Neuronal instability: implications for Rett's syndrome. Brain Dev 2001, 23(Suppl 1):S1-S10.
-
(2001)
Brain Dev
, vol.23
, Issue.SUPPL 1
-
-
Azmitia, E.C.1
-
2
-
-
33846889762
-
[18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain
-
Aznavour N., Zimmer L. [18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain. Neuropharmacology 2007, 52:695-707.
-
(2007)
Neuropharmacology
, vol.52
, pp. 695-707
-
-
Aznavour, N.1
Zimmer, L.2
-
3
-
-
0037040499
-
In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice
-
Bernard-Helary K., Ardourel M.Y., Hevor T., Cloix J.F. In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice. Brain Res 2002, 929:147-155.
-
(2002)
Brain Res
, vol.929
, pp. 147-155
-
-
Bernard-Helary, K.1
Ardourel, M.Y.2
Hevor, T.3
Cloix, J.F.4
-
4
-
-
0037304917
-
Is there a role for 5-HT1A agonists in the treatment of depression?
-
Blier P., Ward N.M. Is there a role for 5-HT1A agonists in the treatment of depression?. Biol Psychiatry 2003, 53:193-203.
-
(2003)
Biol Psychiatry
, vol.53
, pp. 193-203
-
-
Blier, P.1
Ward, N.M.2
-
5
-
-
0029064303
-
The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors
-
Bonhaus D.W., Bach C., DeSouza A., Salazar F.H., Matsuoka B.D., Zuppan P., Chan H.W., Eglen R.M. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 1995, 115:622-628.
-
(1995)
Br J Pharmacol
, vol.115
, pp. 622-628
-
-
Bonhaus, D.W.1
Bach, C.2
DeSouza, A.3
Salazar, F.H.4
Matsuoka, B.D.5
Zuppan, P.6
Chan, H.W.7
Eglen, R.M.8
-
6
-
-
0031057229
-
Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze
-
Cao B.J., Rodgers R.J. Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze. Psychopharmacology (Berl) 1997, 129:365-371.
-
(1997)
Psychopharmacology (Berl)
, vol.129
, pp. 365-371
-
-
Cao, B.J.1
Rodgers, R.J.2
-
7
-
-
0025944364
-
Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain-a combined in situ hybridisation/in vitro receptor autoradiographic study
-
Chalmers D.T., Watson S.J. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain-a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res 1991, 561:51-60.
-
(1991)
Brain Res
, vol.561
, pp. 51-60
-
-
Chalmers, D.T.1
Watson, S.J.2
-
8
-
-
0015861774
-
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
-
Cheng Y., Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973, 22:3099-3108.
-
(1973)
Biochem Pharmacol
, vol.22
, pp. 3099-3108
-
-
Cheng, Y.1
Prusoff, W.H.2
-
9
-
-
13444291123
-
Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze
-
Clenet F., Hascoet M., Fillion G., Galons H., Bourin M. Role of GABA-ergic and serotonergic systems in the anxiolytic-like mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze. Behav Brain Res 2005, 158:339-348.
-
(2005)
Behav Brain Res
, vol.158
, pp. 339-348
-
-
Clenet, F.1
Hascoet, M.2
Fillion, G.3
Galons, H.4
Bourin, M.5
-
10
-
-
0035861850
-
Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells
-
Cosi C., Koek W. Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells. Eur J Pharmacol 2001, 433:55-62.
-
(2001)
Eur J Pharmacol
, vol.433
, pp. 55-62
-
-
Cosi, C.1
Koek, W.2
-
11
-
-
33847354629
-
Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities
-
Cuisiat S., Bourdiol N., Lacharme V., Newman-Tancredi A., Colpaert F., Vacher B. Towards a new generation of potential antipsychotic agents combining D2 and 5-HT1A receptor activities. J Med Chem 2007, 50:865-876.
-
(2007)
J Med Chem
, vol.50
, pp. 865-876
-
-
Cuisiat, S.1
Bourdiol, N.2
Lacharme, V.3
Newman-Tancredi, A.4
Colpaert, F.5
Vacher, B.6
-
12
-
-
52949147789
-
5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders
-
Dawson L.A., Bromidge S.M. 5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders. Curr Top Med Chem 2008, 8:1008-1023.
-
(2008)
Curr Top Med Chem
, vol.8
, pp. 1008-1023
-
-
Dawson, L.A.1
Bromidge, S.M.2
-
13
-
-
0030952588
-
Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe
-
Dong J., de Montigny C., Blier P. Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch Pharmacol 1997, 356:303-311.
-
(1997)
Naunyn Schmiedebergs Arch Pharmacol
, vol.356
, pp. 303-311
-
-
Dong, J.1
de Montigny, C.2
Blier, P.3
-
14
-
-
65549122835
-
Pharmacogenetics of antidepressant response: an update
-
Drago A., De Ronchi D., Serretti A. Pharmacogenetics of antidepressant response: an update. Hum Genomics 2009, 3:257-274.
-
(2009)
Hum Genomics
, vol.3
, pp. 257-274
-
-
Drago, A.1
De Ronchi, D.2
Serretti, A.3
-
15
-
-
0018875386
-
Cyclic GMP and cyclic AMP in the cerebral cortex of mice during seizures induced by 3-mercaptopropionic acid: effects of anticonvulsant agents
-
Folbergrova J. Cyclic GMP and cyclic AMP in the cerebral cortex of mice during seizures induced by 3-mercaptopropionic acid: effects of anticonvulsant agents. Neurosci Lett 1980, 16:291-296.
-
(1980)
Neurosci Lett
, vol.16
, pp. 291-296
-
-
Folbergrova, J.1
-
16
-
-
0028950957
-
Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats
-
Freo U., Pietrini P., Pizzolato G., Furey-Kurkjian M., Merico A., Ruggero S., Dam M., Battistin L. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats. Brain Res 1995, 677:213-220.
-
(1995)
Brain Res
, vol.677
, pp. 213-220
-
-
Freo, U.1
Pietrini, P.2
Pizzolato, G.3
Furey-Kurkjian, M.4
Merico, A.5
Ruggero, S.6
Dam, M.7
Battistin, L.8
-
17
-
-
0026610461
-
Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat
-
Grasby P.M., Sharp T., Allen T., Kelly P.A., Grahame-Smith D.G. Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat. Psychopharmacology (Berl) 1992, 106:97-101.
-
(1992)
Psychopharmacology (Berl)
, vol.106
, pp. 97-101
-
-
Grasby, P.M.1
Sharp, T.2
Allen, T.3
Kelly, P.A.4
Grahame-Smith, D.G.5
-
18
-
-
33748060985
-
Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder
-
Gray L., Scarr E., Dean B. Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder. Psychiatry Res 2006, 143:111-120.
-
(2006)
Psychiatry Res
, vol.143
, pp. 111-120
-
-
Gray, L.1
Scarr, E.2
Dean, B.3
-
19
-
-
0018332473
-
Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors
-
Greengrass P., Bremner R. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors. Eur J Pharmacol 1979, 55:323-326.
-
(1979)
Eur J Pharmacol
, vol.55
, pp. 323-326
-
-
Greengrass, P.1
Bremner, R.2
-
20
-
-
0030912961
-
Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors
-
Hall D.A., Strange P.G. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors. Br J Pharmacol 1997, 121:731-736.
-
(1997)
Br J Pharmacol
, vol.121
, pp. 731-736
-
-
Hall, D.A.1
Strange, P.G.2
-
21
-
-
0037469488
-
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration
-
Hensler J.G. Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sci 2003, 72:1665-1682.
-
(2003)
Life Sci
, vol.72
, pp. 1665-1682
-
-
Hensler, J.G.1
-
22
-
-
0022877263
-
Glycogen synthesis and immunocytochemical study of fructose-1,6-biphosphatase in methionine sulfoximine epileptogenic rodent brain
-
Hevor T.K., Delorme P., Beauvillain J.C. Glycogen synthesis and immunocytochemical study of fructose-1,6-biphosphatase in methionine sulfoximine epileptogenic rodent brain. J Cereb Blood Flow Metab 1986, 6:292-297.
-
(1986)
J Cereb Blood Flow Metab
, vol.6
, pp. 292-297
-
-
Hevor, T.K.1
Delorme, P.2
Beauvillain, J.C.3
-
23
-
-
0034123688
-
Serotonin autoreceptor function and antidepressant drug action
-
Hjorth S., Bengtsson H.J., Kullberg A., Carlzon D., Peilot H., Auerbach S.B. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol 2000, 14:177-185.
-
(2000)
J Psychopharmacol
, vol.14
, pp. 177-185
-
-
Hjorth, S.1
Bengtsson, H.J.2
Kullberg, A.3
Carlzon, D.4
Peilot, H.5
Auerbach, S.B.6
-
24
-
-
0022273541
-
Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol
-
Hoyer D., Engel G., Kalkman H.O. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. Eur J Pharmacol 1985, 118:1-12.
-
(1985)
Eur J Pharmacol
, vol.118
, pp. 1-12
-
-
Hoyer, D.1
Engel, G.2
Kalkman, H.O.3
-
25
-
-
0014783247
-
Physiological and drug-induced changes in the glycogen content of mouse brain
-
Hutchins D.A., Rogers K.J. Physiological and drug-induced changes in the glycogen content of mouse brain. Br J Pharmacol 1970, 39:9-25.
-
(1970)
Br J Pharmacol
, vol.39
, pp. 9-25
-
-
Hutchins, D.A.1
Rogers, K.J.2
-
26
-
-
0015147024
-
Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine
-
Hutchins D.A., Rogers K.J. Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine. Br J Pharmacol 1971, 43:504-513.
-
(1971)
Br J Pharmacol
, vol.43
, pp. 504-513
-
-
Hutchins, D.A.1
Rogers, K.J.2
-
27
-
-
0015619776
-
Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain
-
Hutchins D.A., Rogers K.J. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain. Br J Pharmacol 1973, 48:19-29.
-
(1973)
Br J Pharmacol
, vol.48
, pp. 19-29
-
-
Hutchins, D.A.1
Rogers, K.J.2
-
28
-
-
0037177358
-
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
-
Jordan S., Koprivica V., Chen R., Tottori K., Kikuchi T., Altar C.A. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 2002, 441:137-140.
-
(2002)
Eur J Pharmacol
, vol.441
, pp. 137-140
-
-
Jordan, S.1
Koprivica, V.2
Chen, R.3
Tottori, K.4
Kikuchi, T.5
Altar, C.A.6
-
29
-
-
2442702676
-
Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers
-
Joseph S.S., Lynham J.A., Colledge W.H., Kaumann A.J. Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers. Naunyn Schmiedebergs Arch Pharmacol 2004, 369:525-532.
-
(2004)
Naunyn Schmiedebergs Arch Pharmacol
, vol.369
, pp. 525-532
-
-
Joseph, S.S.1
Lynham, J.A.2
Colledge, W.H.3
Kaumann, A.J.4
-
30
-
-
59149099752
-
Current considerations in the treatment of generalized anxiety disorder
-
Katzman M.A. Current considerations in the treatment of generalized anxiety disorder. CNS Drugs 2009, 23:103-120.
-
(2009)
CNS Drugs
, vol.23
, pp. 103-120
-
-
Katzman, M.A.1
-
31
-
-
34548413531
-
PET tracers for 5-HT(1A) receptors and uses thereof
-
Kumar J.S., Mann J.J. PET tracers for 5-HT(1A) receptors and uses thereof. Drug Discov Today 2007, 12:748-756.
-
(2007)
Drug Discov Today
, vol.12
, pp. 748-756
-
-
Kumar, J.S.1
Mann, J.J.2
-
32
-
-
0033827305
-
Central 5-HT(1A) receptors: regional distribution and functional characteristics
-
Lanfumey L., Hamon M. Central 5-HT(1A) receptors: regional distribution and functional characteristics. Nucl Med Biol 2000, 27:429-435.
-
(2000)
Nucl Med Biol
, vol.27
, pp. 429-435
-
-
Lanfumey, L.1
Hamon, M.2
-
33
-
-
34047252354
-
Reduced serotonin-1A receptor binding in social anxiety disorder
-
Lanzenberger R.R., Mitterhauser M., Spindelegger C., Wadsak W., Klein N., Mien L.K., Holik A., Attarbaschi T., Mossaheb N., Sacher J., Geiss-Granadia T., Kletter K., Kasper S., Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 2007, 61:1081-1089.
-
(2007)
Biol Psychiatry
, vol.61
, pp. 1081-1089
-
-
Lanzenberger, R.R.1
Mitterhauser, M.2
Spindelegger, C.3
Wadsak, W.4
Klein, N.5
Mien, L.K.6
Holik, A.7
Attarbaschi, T.8
Mossaheb, N.9
Sacher, J.10
Geiss-Granadia, T.11
Kletter, K.12
Kasper, S.13
Tauscher, J.14
-
34
-
-
0027336835
-
Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation
-
Lazareno S., Birdsall N.J. Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation. Trends Pharmacol Sci 1993, 14:237-239.
-
(1993)
Trends Pharmacol Sci
, vol.14
, pp. 237-239
-
-
Lazareno, S.1
Birdsall, N.J.2
-
35
-
-
0034694934
-
Balance control and posture differences in the anxious BALB/cByJ mice compared to the non anxious C57BL/6J mice
-
Lepicard E.M., Venault P., Perez-Diaz F., Joubert C., Berthoz A., Chapouthier G. Balance control and posture differences in the anxious BALB/cByJ mice compared to the non anxious C57BL/6J mice. Behav Brain Res 2000, 117:185-195.
-
(2000)
Behav Brain Res
, vol.117
, pp. 185-195
-
-
Lepicard, E.M.1
Venault, P.2
Perez-Diaz, F.3
Joubert, C.4
Berthoz, A.5
Chapouthier, G.6
-
36
-
-
0037163005
-
The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation
-
Levin M.C., Marullo S., Muntaner O., Andersson B., Magnusson Y. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 2002, 277:30429-30435.
-
(2002)
J Biol Chem
, vol.277
, pp. 30429-30435
-
-
Levin, M.C.1
Marullo, S.2
Muntaner, O.3
Andersson, B.4
Magnusson, Y.5
-
37
-
-
33645018616
-
Effects of 5-HT on memory and the hippocampus: model and data
-
Meeter M., Talamini L., Schmitt J.A., Riedel W.J. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology 2006, 31:712-720.
-
(2006)
Neuropsychopharmacology
, vol.31
, pp. 712-720
-
-
Meeter, M.1
Talamini, L.2
Schmitt, J.A.3
Riedel, W.J.4
-
38
-
-
0345258416
-
Serotonin receptors: their key role in drugs to treat schizophrenia
-
Meltzer H.Y., Li Z., Kaneda Y., Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27:1159-1172.
-
(2003)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.27
, pp. 1159-1172
-
-
Meltzer, H.Y.1
Li, Z.2
Kaneda, Y.3
Ichikawa, J.4
-
39
-
-
0033696731
-
Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors
-
Millan M.J. Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. J Pharmacol Exp Ther 2000, 295:853-861.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 853-861
-
-
Millan, M.J.1
-
40
-
-
0036156725
-
Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor
-
Morisset S., Pilon C., Tardivel-Lacombe J., Weinstein D., Rostene W., Betancur C., Sokoloff P., Schwartz J.C., Arrang J.M. Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor. J Pharmacol Exp Ther 2002, 300:621-628.
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 621-628
-
-
Morisset, S.1
Pilon, C.2
Tardivel-Lacombe, J.3
Weinstein, D.4
Rostene, W.5
Betancur, C.6
Sokoloff, P.7
Schwartz, J.C.8
Arrang, J.M.9
-
41
-
-
0028180705
-
Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s)
-
Mulheron J.G., Casanas S.J., Arthur J.M., Garnovskaya M.N., Gettys T.W., Raymond J.R. Human 5-HT1A receptor expressed in insect cells activates endogenous G(o)-like G protein(s). J Biol Chem 1994, 269:12954-12962.
-
(1994)
J Biol Chem
, vol.269
, pp. 12954-12962
-
-
Mulheron, J.G.1
Casanas, S.J.2
Arthur, J.M.3
Garnovskaya, M.N.4
Gettys, T.W.5
Raymond, J.R.6
-
42
-
-
0024548023
-
2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites
-
Naiman N., Lyon R.A., Bullock A.E., Rydelek L.T., Titeler M., Glennon R.A. 2-(Alkylamino)tetralin derivatives: interaction with 5-HT1A serotonin binding sites. J Med Chem 1989, 32:253-256.
-
(1989)
J Med Chem
, vol.32
, pp. 253-256
-
-
Naiman, N.1
Lyon, R.A.2
Bullock, A.E.3
Rydelek, L.T.4
Titeler, M.5
Glennon, R.A.6
-
43
-
-
0031698286
-
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study
-
Newman-Tancredi A., Gavaudan S., Conte C., Chaput C., Touzard M., Verriele L., Audinot V., Millan M.J. Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study. Eur J Pharmacol 1998, 355:245-256.
-
(1998)
Eur J Pharmacol
, vol.355
, pp. 245-256
-
-
Newman-Tancredi, A.1
Gavaudan, S.2
Conte, C.3
Chaput, C.4
Touzard, M.5
Verriele, L.6
Audinot, V.7
Millan, M.J.8
-
44
-
-
0015505764
-
Barbiturate-induced glycogen accumulation in brain. An electron microscopic study
-
Phelps C.H. Barbiturate-induced glycogen accumulation in brain. An electron microscopic study. Brain Res 1972, 39:225-234.
-
(1972)
Brain Res
, vol.39
, pp. 225-234
-
-
Phelps, C.H.1
-
45
-
-
0025332575
-
Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors
-
Richards M.H. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors. Br J Pharmacol 1990, 99:753-761.
-
(1990)
Br J Pharmacol
, vol.99
, pp. 753-761
-
-
Richards, M.H.1
-
46
-
-
62849085070
-
Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder
-
Sato Y., Yasui-Furukori N., Nakagami T., Saito M., Kaneko S. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:416-418.
-
(2009)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.33
, pp. 416-418
-
-
Sato, Y.1
Yasui-Furukori, N.2
Nakagami, T.3
Saito, M.4
Kaneko, S.5
-
47
-
-
0033976134
-
Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis
-
Silva R.C., Brandao M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 2000, 65:209-216.
-
(2000)
Pharmacol Biochem Behav
, vol.65
, pp. 209-216
-
-
Silva, R.C.1
Brandao, M.L.2
-
48
-
-
0032845187
-
Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation
-
Sprouse J.S., Reynolds L.S., Braselton J.P., Rollema H., Zorn S.H. Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation. Neuropsychopharmacology 1999, 21:622-631.
-
(1999)
Neuropsychopharmacology
, vol.21
, pp. 622-631
-
-
Sprouse, J.S.1
Reynolds, L.S.2
Braselton, J.P.3
Rollema, H.4
Zorn, S.H.5
-
49
-
-
61749086565
-
Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics
-
Sumiyoshi T., Bubenikova-Valesova V., Horacek J., Bert B. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. Adv Ther 2008, 25:1037-1056.
-
(2008)
Adv Ther
, vol.25
, pp. 1037-1056
-
-
Sumiyoshi, T.1
Bubenikova-Valesova, V.2
Horacek, J.3
Bert, B.4
-
50
-
-
34548189417
-
Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study
-
Sumiyoshi T., Park S., Jayathilake K., Roy A., Ertugrul A., Meltzer H.Y. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. Schizophr Res 2007, 95:158-168.
-
(2007)
Schizophr Res
, vol.95
, pp. 158-168
-
-
Sumiyoshi, T.1
Park, S.2
Jayathilake, K.3
Roy, A.4
Ertugrul, A.5
Meltzer, H.Y.6
-
51
-
-
0015950112
-
Reserpine-induced glycogen accumulation in the epithelial cells of the mouse choroid plexus
-
Suzuki Y., Ito T. Reserpine-induced glycogen accumulation in the epithelial cells of the mouse choroid plexus. Brain Res 1974, 70:113-122.
-
(1974)
Brain Res
, vol.70
, pp. 113-122
-
-
Suzuki, Y.1
Ito, T.2
-
52
-
-
0026001906
-
Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding
-
Uhlen S., Wikberg J.E. Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding. Pharmacol Toxicol 1991, 69:341-350.
-
(1991)
Pharmacol Toxicol
, vol.69
, pp. 341-350
-
-
Uhlen, S.1
Wikberg, J.E.2
-
53
-
-
67650081409
-
'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity
-
Zhang J., Zhang H., Cai W., Yu L., Zhen X., Zhang A. (2009)'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity. Bioorg Med Chem 2009, 17:4873-4880.
-
(2009)
Bioorg Med Chem
, vol.17
, pp. 4873-4880
-
-
Zhang, J.1
Zhang, H.2
Cai, W.3
Yu, L.4
Zhen, X.5
Zhang, A.6
-
54
-
-
0025126624
-
Cloning and expression of human and rat D1 dopamine receptors
-
Zhou Q.Y., Grandy D.K., Thambi L., Kushner J.A., Van Tol H.H., Cone R., Pribnow D., Salon J., Bunzow J.R., Civelli O. Cloning and expression of human and rat D1 dopamine receptors. Nature 1990, 347:76-80.
-
(1990)
Nature
, vol.347
, pp. 76-80
-
-
Zhou, Q.Y.1
Grandy, D.K.2
Thambi, L.3
Kushner, J.A.4
Van Tol, H.H.5
Cone, R.6
Pribnow, D.7
Salon, J.8
Bunzow, J.R.9
Civelli, O.10
|